Deletions of 17p and p53 Mutations in Preneoplastic Lesions of the Lung

Cancer Research

Volumn 52, Issue 21, 1992, Pages 6079-6082

  Pastorino, Ugo ^b   Miozzo, Monica ^a   Donghi, Rosangela ^a   Cariani, Claudia T ^a   Delia Porta, Giuseppe ^a   Pierotti, Marco A ^a  

^a Divisions of Experimental Oncology ^*  (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; BRONCHUS MUCOSA; CHROMOSOME 17P; CHROMOSOME DELETION; EPITHELIUM DYSPLASIA; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LUNG CANCER; LUNG CARCINOGENESIS; LUNG DYSPLASIA; PRECANCER; PRIORITY JOURNAL;

BASE SEQUENCE; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 17; GENES, P53; HUMAN; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; PRECANCEROUS CONDITIONS; SUPPORT, NON-U.S. GOV'T;

EID: 0026445666     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Minna, J. D., Battey, J. F., Brooks, B. J., et al. Molecular genetic analysis reveals chromosomal alterations, gene amplification, and autocrine growth factor production in the pathogenesis of human lung cancer. Cold Spring Harbor Symp. Quant. Biol., 57: 843-853, 1986.
2. Minna, J. D., Schutte, J., Viallet, J., Thomas, F., Kaye, F. J., Takahashi, T., Nau, M., Whang-Peng, J., Birrer, M., and Gazdar, A. F. Transcription factors and recessive oncogenes in the pathogenesis of human lung cancer. Int. J. Cancer, 4: 32-34, 1989.
3. Birrer, M. J., and Brown, P. H. Application of molecular genetics to the early diagnosis and screening of lung cancer. Cancer Res., 52 (Suppl.); 2658s-2664s, 1992.
4. Takahashi, T., Nau, M. M., Chiba, I., et al p53: a frequent target for genetic abnormalities in lung cancer. Science (Washington DC), 246:491-494,1989.
5. Iggo, R., Gatter, K., Bartek, J., Lane, D., and Harris, A. L. Increased expression of mutant forms of p5S oncogene in primary lung cancer. Lancet, 335: 675-679, 1990.
6. Chiba, L., Takahashi, T., Nau, M., D'Amico, D., Curiel, D., Mitsudomi, T. D. B., Carbone, D., Piantadosi, S., Koga, H., Reissmann, P., Slamon, D., Holmes, E., and Minna, J. Mutations in the 5i gene are frequent in primary, resected non-small cell lung cancer. Oncogene, 5: 1603-1610, 1990.
7. Takahashi, T., Carbone, D., Takahashi, T., Nau, M. M., Hida, T., Linnoila, L., Ueda, R., and Minna, J. D. Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions. Cancer Res. 52:2340-2343 1992.
8. Vahkangas, K. H., Samet, J. M., Metcalf, R. A., Welsh, J. A., Bennett, W. P., Lane, D. P., and Harris, C. C. Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet, 339: 576-580, 1992.
9. Sozzi, G., Miozzo, M., Tagliabue, E., Calderone, C., Lombardi, L., Pilotti, S., Pastorino, U., Pierotti, M. A., and Della Porta, G. Cytogenetic abnormalities and overexpression of receptors for growth factors in normal bronchial epithelium and tumor samples of lung cancer patients. Cancer Res., 51: 400-404, 1991.
10. Gibas, L. M., Gibas, Z., and Sandberg, A. A. Technical aspects of cytogenetic analysis of human solid tumors. Karyogram, 10: 25-27, 1984.
11. ISCN. An International System for Human Cytogenetic Nomenclature. Birth Defects Orig. Artie. Ser., 21: 1, 1985.
12. Frigo, B., Scopsi, L., Patriarca, C., and Rilke, F. Silver enhancement of nickel-diaminobenzidine as applied to single and double immunoperoxidase staining. Biotech. Histochem., 1: 159, 1991.
13. Gannon, J. V., Greaves, R., Iggo, R., and Lane, D. P. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific of the mutant form. EMBO J., 9: 1595-1601, 1990.
14. Gerdes, J., Becker, M. H. G., Key, G., and Cattoretti, G. Immunohistological detection of tumor growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J. Pathol., in press, 1992.
15. Shi, S-R., Key, M. E., and Kalra, K. L. Antigen retrieval in formalin-fixed, parafiln-embedded tissues: an enhancement method for immunocytochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem., 39: 741-748, 1991.
16. Molecular Cloning. A Laboratory Manual. J. Sambrook, E. F. Fritsch, and T. Maniatis (eds.), Ed. 2, Vol. 9, pp. 16-17. New York: Cold Spring Harbor Laboratory Press, 1989.
17. Gaidano, G., Ballerini, P., Gong, J. Z., Inghirami, G., Neri, A., Newcomb, E. W., Magrath, I. T., Knowles, D. M., and Dalla-Favera, R. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA, 88:5413-5417, 1991.
18. Murray, V. Improved double-stranded DNA sequencing using the linear polymerase chain reaction. Nucleic Acids Res., 17: 88-89, 1989.
19. Rabbitts, P. H., Sundaresan, V., Ganly, P. S., Hasleton, P., Rudd, R. M., and Sinha, G. Application of PCR-RFLP analysis to allele loss studies in small biopsies of lung tumors and preinvasive lesions of the lung. Third European Workshop on Cytogenetics and Molecular Genetics of Human Solid Tumors. Porto, April 26-29, 1992.
20. Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Nakamura, Y., White, R., Smits, A. M. M., and Bos, J. L. Genetic alterations during colorectal-tumor development. N. Engl. J. Med., 319: 525-532, 1988.
21. Mazars, R., Pujol, P., Maudelonde, T., Jeanteur, P., and Theillet, C. p53 mutations in ovarian cancer: a late event? Oncogene, 6: 1685-1690, 1991.
22. Ito, T., Seyama, T., Mizuno, T., Tsuyama, N., Hayashi, T., Hayashi, Y., Dohi, K., Nakamura, N., and Akiyama, M. Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. Cancer Res., 52: 1369-1371, 1992.